RT Journal Article
SR Electronic
T1 Distance from home to motor vehicle crash location: Implications for license restrictions among medically-at-risk older drivers
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.08.20.21262345
DO 10.1101/2021.08.20.21262345
A1 Joyce, Nina R.
A1 Khan, Marzan A.
A1 Zullo, Andrew R.
A1 Pfeiffer, Melissa R.
A1 Metzger, Kristina B.
A1 Margolis, Seth A.
A1 Ott, Brian R.
A1 Curry, Allison E.
YR 2021
UL http://medrxiv.org/content/early/2021/08/25/2021.08.20.21262345.abstract
AB Background/Objectives Thirty states allow licensing agencies to restrict the distance from home that “medically-at-risk” drivers are permitted to drive. However, there is little information on where older drivers crash relative to their home or how distance to crash varies by medical condition, and thus, what impact distance limits may have on motor vehicle crash rates for “medically-at-risk” drivers.Design Observational study of crash-involved drivers.Setting Medicare fee-for-service claims linked to geocoded crash locations and residential addresses from police crash reports in the state of New Jersey from 2007 through 2017.Participants New Jersey Medicare fee-for-service beneficiaries aged 68 years and older involved in police-reported crashes.Measurements The outcome was Euclidian distance from home to crash location. Covariates included driving-relevant medical conditions from Medicare claims, crash characteristics from police reports, and demographics from both sources.Results There were 197,122 crash-involved older drivers for whom approximately 70% of crashes occurred within 5 miles and 95% within 25 miles of the driver’s residence. The mean distance to crash was 6.0 miles. Although distance from home to the crash was generally lower among drivers with (versus without) each of the medical conditions studied, the differences were small (maximum mean difference of 2.1 miles). The largest difference in distance was by licensure status, where unlicensed/suspended drivers crashed significantly farther from home than validly licensed drivers (8.8 miles, 95% Confidence Interval [CI]: 8.4-9.1 vs 5.9 miles, 95% CI: 5.9 – 6.0).Conclusions Findings suggest that the majority of older adults who crash do so within a few miles from home and that the distance to crash does not differ substantially by the presence of a driving-relevant medical condition. Thus, distance restrictions may not reduce crash rates among older adults and the tradeoff between safety and mobility warrants consideration.KEYPOINTS30 states permit restriction of driving distance for medically-at-risk driversThe vast majority of crashes involving older drivers occur ≤ 25 miles of homeDistance to crash does not differ markedly across driving-relevant medical conditionsWhy does this matter?Distance restrictions are likely to impact mobility and autonomy but not crash ratesCompeting Interest StatementThe authors have declared no competing interest.Funding StatementThis work was funded by grant from the National Institute on Aging (NIA), award number R01AG065722 (PI: Zullo, CoI: Joyce, Curry, Pfeiffer, Margolis, Ott); two pilot grants from the Brown University Office of the Vice President for Research (PI: Zullo and Joyce); a pilot grant from the Albert and Elaine Borchard Foundation (PI: Joyce); and grants from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), award numbers R21HD092850 (PI: Curry; CoI: Pfeiffer) and R21HD098276 (PI: Curry; CoI: Joyce, Metzger).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Brown IRBAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data are not publicly available